Sympathetic Activity in Patients With Secondary Symptomatic Mitral Regurgitation or End-Stage Systolic Heart Failure

详细信息    查看全文

• 作者：Can Ö ; ztü ; rk ; MD^a ; Robert Schueler ; MD^a ; Marcel Weber ; MD^a ; Armin Welz ; MD^b ; Nikos Werner ; MD^a ; Georg Nickenig ; MD^a ; Christoph Hammerstingl ; MD^a ; ^{christoph.hammerstingl@ukb.uni-bonn.de" class="auth_mail" title="E-mail the corresponding author}
• 关键词：MitraClip ; muscle sympathetic nerve activity ; TMVR ; mitral regurgitation ; sympathetic nerve activity
• 刊名：JACC: Cardiovascular Interventions
• 出版年：2016
• 出版时间：10 October 2016
• 年：2016
• 卷：9
• 期：19
• 页码：2050-2057
• 全文大小：860 K

文摘

This study shows the impact of secondary mitral regurgitation (sMR) and transcatheter mitral valve repair (TMVR) with the MitraClip system on sympathetic nerve activity (SNA).

Background

An increase in SNA is associated with worse outcomes and limited survival in patients with chronic heart failure (CHF).

Methods

Twenty CHF-patients without relevant sMR and 30 CHF patients with symptomatic sMR were enrolled prospectively. All patients underwent standardized laboratory testing and microneurography. Sixteen patients from the sMR group underwent the MitraClip procedure; 10 patients after TMVR and 9 untreated sMR patients completed 6 months of follow-up.

Results

Comparing groups according to presence of sMR, we found no differences in left ventricular dimensions, and serum levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) and noradrenaline; sMR was associated with increased MSNA (106 ± 60 burst/min vs. 74 ± 48 burst/min, d = 0.58), an impaired sympathetic baroreflex gain (10 ± 7 burst/mm Hg vs. 5 ± 5 burst/mm Hg, d = 0.61), and a higher heart rate (90 ± 27/beats/min vs. 78 ± 12/beats/min, d = 0.58). TMVR led to improved New York Heart Association functional class (d > 0.05), reduced levels of NT-proBNP (5,251 ± 3,760 pg/ml vs. 3,710 ± 2,464 pg/ml; d = 0.58) improvement in 6-minute walk test (204 ± 33 m vs. 288 ± 45 m, d = 0.64), but unchanged levels of noradrenaline. TMVR decreased MSNA burst-frequency (130 ± 78 bursts/min vs. 74 ± 21 bursts/min; d = 0.58) and baroreflex gain (7 ± 4 burst/mm Hg vs. 4 ± 1 burst/mm Hg; d = 0.61).

Conclusions

In patients with CHF, concomitant sMR is associated with increased sympathetic nerve activity, which was independent from measured levels of NT-proBNP, noradrenaline, and left ventricular dimensions. Reduction of sMR with the MitraClip procedure reduced SNA and improved baroreflex gain, in line with improvements of functional capacity.